Covered recipient · General Payments record
OLUFOLAKEMI O AWE
Allopathic & Osteopathic Physicians Dermatology MOHS-Micrographic Surgery
General Payments · PY2019–2025
$591.47
- Reported across 21 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $301.63 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $143.13 | 10 |
| GENZYME CORPORATION | $53.87 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $35.29 | 2 |
| Regeneron Healthcare Solutions, Inc. | $32.78 | 1 |
| LNHC, Inc | $21.01 | 1 |
| ORGANOGENESIS INC. | $15.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.00 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447565 | CMS |
| ABBVIE INC. | $14.90 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447567 | CMS |
| ABBVIE INC. | $20.00 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447569 | CMS |
| ABBVIE INC. | $2.89 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447571 | CMS |
| ABBVIE INC. | $15.97 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447573 | CMS |
| ABBVIE INC. | $26.85 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447575 | CMS |
| ABBVIE INC. | $15.10 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447577 | CMS |
| ABBVIE INC. | $14.91 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447579 | CMS |
| ABBVIE INC. | $4.50 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447581 | CMS |
| ABBVIE INC. | $23.01 | 12/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201447583 | CMS |
| GENZYME CORPORATION | $21.25 | 04/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233592715 | CMS |
| GENZYME CORPORATION | $32.62 | 12/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233592827 | CMS |
| LNHC, Inc | $21.01 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242601108 | CMS |
| Organogenesis Inc. | $15.55 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241996793 | CMS |
| Regeneron Healthcare Solutions, Inc. | $32.78 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212865952 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $20.55 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251043501 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.74 | 11/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251043503 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.